Interview with Carlos Mayotti, Commercial Director, Phoenix
How has Phoenix developed from being the family company that was founded seventy years ago into the successful corporate business it is today? I joined Phoenix in 1989, at that…
Address: Ave Gen. J. Lemos 2809 (B1614BDH). Villa de Mayo. Buenos Aires. Argentina.
Tel: (54-11) 4489-8300
Web: http://www.phoenix.com.ar/
A Commitment to Health is what characterizes the more than half-a-century of activity carried out by Laboratorios Phoenix, a pioneer in offering to the domestic market the product of state-of-the-art international research, including the first antibiotics and antipoliomyelitic vaccines.
Throughout its trajectory, Laboratorios Phoenix has contributed to the growth of the Argentine pharmaceutical industry, assuring up-to-date scientific dissemination and production of drugs according to the most demanding standards of quality control.
As a licensee, Laboratorios Phoenix has demonstrated in its production an entrepreneurial soundness and scientific rigor in accordance with the standards of important foreign laboratories. And as a result of creative innovation, it has also made its own achievements in the field of leading edge research, developing state-of-the art technology in the area of oral drug delivery and controlled drug release.
Opthamology, Dermatology, Neurological, Respiratory
How has Phoenix developed from being the family company that was founded seventy years ago into the successful corporate business it is today? I joined Phoenix in 1989, at that…
The president of Denver Farma explains how crucial exports are for his company, especially to countries like Brazil where the market participation of local companies is small, and multinational companies…
Edgardo Vázquez, Pfizer’s country manager for the Argentina Region, discusses the company’s investment strategies across their newly established business units and a few of the unique challenges presented by the…
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. Could you provide a historical overview…
The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated generics. Could you please…
The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines and becoming a pure pharmaceutical company. …
The general director of pharma in Argentina for the Bagó group explains why his group has planned that 75 percent of turnover will come from international markets in the coming years. 2014 marks…
The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country’s ambitions in this area, which is to have an impact on innovation at…
The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you please provide an historical overview of Argenomics? Several…
The general manager of Ferring Argentina believes that the country has one of the strongest social security systems in Latin America, with high reimbursement levels and coverage for most chronic…
The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in the region for Roche, and…
The general manager of Gennoma Laboratorios Argentina weighs up the factors of why raising brand awareness using public television is the key success to his company communication strategy. When…
See our Cookie Privacy Policy Here
